Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
CA 2298779 A1 · Owner: Rupniak, Nadia Melanie · Inventors: Rupniak, Nadia Melanie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides the use of an NK-1 receptor antagonist and , optionally an antipsychotic agent for the manufacture of a medicament for the treatment or prevention of aggressive behaviour methods of treatment using , such an NK-1 receptor antagonist and pharmaceutical compositions and products comprising it.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 31, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 31, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 31, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.